Affordable Medicines Europe compiled in one reports the most recent studies on direct and indirect savings in Germany, Sweden, Denmark and Poland. The total amount of savings in these four countries added up to €3.2 billion. For Sweden and Germany, the savings figures account for those of the pharmacy market alone, while for Denmark and Poland they also include the parallel imports supplied to hospitals.

Links to the studies on savings:

– Financial Impact of Pharmaceutical Imports on Healthcare

– Indirect Savings from Parallel Trade in the Pharmaceutical Sector: the German and the Swedish cases

– Secondary analysis of indirect savings effects and potentials of parallel imports of pharmaceuticals

– The impact of import on the competitive situation on the market for medicinal products in Poland in the years 2010-2018